Prosthetic Heart Valves Market - Size, Share, Growth, Outlook, and Opportunity Analysis, 2018-2026 Heart valves play an important role in controlling the blood flow to and from the heart. The heart consists of four main types of valves that are tricuspid, pulmonary, mitral, and aortic valves. Prosthetic heart valves are commonly known as artificial valves that implanted in the heart of the patients suffering from the valvular heart disease. Thus, the surging incidence of heart disorders drives the prosthetic heart valve market over the forecast period. There are 3 types of prosthetic heart valve such as mechanical heart valve, tissue heart valve, and transcatheter heart valve.
Request Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/69
Market Dynamics The aging population and increasing patient population of heart disease are expected to drive demand for prosthetic heart valve-based treatment in the future. For instance, According to the statistics of World Health Organization in 2012, 17.6 million people died of cardiovascular disease (CVD) worldwide, and proportionally, this accounts for 31.43% of global mortality. Moreover, The emergence of valve-in-valve procedures serves as a significant market opportunity for the prosthetic heart valve.
Growing Aging Population and prevalence of valvular disease spur growth of the prosthetic heart valve market Increasing geriatric population and prevalence of valvular heart disease will boost the demand of prosthetic heart valves market. According to the National Centre for Health Statistics, 2011, Heart disease is the leading cause of death in the U.S., killing more than 600,000 Americans each year. Continue focusing to advance surgical replacement technologies for patients with diseased, damaged or malfunctioning heart valves by manufacturers is expected to create a lucrative opportunities for the market over the forecast period. For instance, in 2017, Edwards Lifesciences Corporation received U.S. FDA approval for aortic and mitral valve-in-valve
procedures using the Edwards SAPIEN 3 transcatheter heart valve. The SAPIEN 3 valve is the first transcatheter heart valve approved in the U.S. for the treatment of both aortic and mitral patients who are at high risk for a subsequent open-heart surgery to replace their bioprosthetic valve. On the contrary, the high costs associated with the devices mainly transcatheter aortic valve replacement devices and stringent government regulations may hamper the growth of the market.
Report includes chapters which deeply display the following deliverable about industry : • Prosthetic Heart Valves Market Research Objective and Assumption • Prosthetic Heart Valves Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Prosthetic Heart Valves Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Prosthetic Heart Valves Market, By Regions • Prosthetic Heart Valves Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Prosthetic Heart Valves Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Prosthetic Heart Valves Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Prosthetic Heart Valves Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion The key players operating in the global prosthetic heart valves market include Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronic plc, LivaNova PLC, Abbott, Jenavalve Technology, Inc., Lepu Medical Technology Co., Ltd., CryoLife, Inc., and Neovasc Inc.
Inquire Here Before Purchase:
https://www.coherentmarketinsights.com/insight/talk-to-analyst/69
Detailed Segmentation: • Global Prosthetic Heart Valves Market, By Product Type: • Transcatheter Heart Valves • Mechanical Heart Valves • Tissue Heart Valves • Global Prosthetic Heart Valves Market, By End User: • Hospitals • Ambulatory Surgical Centers • Global Prosthetic Heart Valves Market, By Geography: • North America • Europe • Asia Pacific • Latin America • Middle East • Africa
About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com